What Is APOE And Why Am I Getting Tested For It?

Alzheimer's disease (AD) affects more than 5 million Americans. APOE — apolipoprotein E — is the most common identified genetic variant associated with risk. Three isoforms exist: ε2, ε3, and ε4. About 25% of people carry one copy of APOE4; about 2–3% carry two copies. APOE2 is rare and protective.

People with one copy of E4 have roughly three times the lifetime risk of AD; two copies, roughly twelve times. These genetic variants are not determinative — they are risk factors, and risk can be mitigated through aggressive lifestyle interventions.

The science: APOE in Alzheimer's disease

APOE plays a role in lipid metabolism, neuronal repair, and synaptic plasticity. APOE4 drives earlier amyloid pathology; APOE2 appears to clear amyloid more efficiently.

Could the answer be in DNA? Benefits of testing

1. Early detection and diagnosis support.
2. Prognostic information for healthcare planning.
3. Clinical trial enrollment opportunities.
4. Personalized and targeted treatment approaches.

Ethical considerations

APOE results have modest predictive value — most APOE4 carriers never develop AD. Testing also raises possibilities of anxiety, depression, and familial implications, since genetic information is shared. Pre-test counseling is important.

How is the APOE test completed?

Our providers at Thema Brain Health order the genetic test through a local lab. The specimen can be collected via blood draw or buccal (cheek) swab. Results usually take 4–7 days.